HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maryam Nasimi Selected Research

diphenylcyclopropenone

5/2022Treatment satisfaction and response in patients with severe alopecia areata under treatment with diphenylcyclopropenone.
11/2021Is the severity of initial sensitization to diphenylcyclopropenone in alopecia areata patients predictive of the final clinical response?
10/2021A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
11/2020Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
5/2020Utility of Dermoscopic Evaluation in Predicting Clinical Response to Diphencyprone in a Cohort of Patients with Alopecia Areata.
10/2019Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maryam Nasimi Research Topics

Disease

8Alopecia Areata
05/2022 - 05/2019
4Cicatrix (Scar)
10/2022 - 01/2018
4Neoplasms (Cancer)
01/2021 - 01/2019
3Alopecia (Baldness)
11/2021 - 02/2019
3Bullous Pemphigoid (Pemphigoid)
02/2020 - 07/2018
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 09/2017
2Actinic Keratosis
05/2022 - 11/2020
2Erythema
05/2022 - 12/2020
2Nevus (Nevi)
02/2022 - 01/2021
2Wounds and Injuries (Trauma)
12/2021 - 01/2018
2Infections
11/2021 - 01/2019
2COVID-19
11/2021 - 10/2021
2Hypertrophic Cicatrix (Hypertrophic Scar)
12/2020 - 01/2018
2Pemphigus (Pemphigus Vulgaris)
10/2020 - 01/2019
2Inflammation (Inflammations)
06/2020 - 05/2019
2Skin Neoplasms (Skin Cancer)
01/2020 - 01/2019
1Surgical Wound
10/2022
1Melanosis (Freckles)
10/2022
1Arthritis (Polyarthritis)
05/2022
1Ulcer
05/2022
1Blister (Bulla)
03/2022
1Lichen Planus (Lichen Ruber Planus)
03/2022
1Mycosis Fungoides
02/2022
1Pigmented Nevus (Melanocytic Nevus)
02/2022
1Skin Diseases (Skin Disease)
02/2022
1Skin Manifestations
01/2022
1Tinea Versicolor (Pityriasis Versicolor)
08/2021
1Stevens-Johnson Syndrome (Lyell's Syndrome)
05/2021
1Eosinophilia
06/2020
1Melanoma (Melanoma, Malignant)
04/2020
1Merkel Cell Carcinoma
01/2020
1Carcinogenesis
01/2020
1Urticaria (Hives)
07/2019
1Heart Failure
01/2019
1Cardiac Arrhythmias (Arrythmia)
01/2019
1Anaphylaxis (Anaphylactic Shock)
01/2019
1Immediate Hypersensitivity
01/2019
1Tuberculosis (Tuberculoses)
01/2019
1Keloid
01/2018

Drug/Important Bio-Agent (IBA)

6diphenylcyclopropenoneIBA
05/2022 - 10/2019
3AutoantibodiesIBA
03/2022 - 06/2020
2Biological ProductsIBA
05/2022 - 10/2021
2SaltsIBA
11/2021 - 05/2020
2Type A Botulinum Toxins (Botox)FDA Link
10/2021 - 12/2020
2Anthralin (Dithranol)IBA
10/2021 - 10/2019
2Proteins (Proteins, Gene)FDA Link
08/2021 - 01/2019
2Immunoglobulin G (IgG)IBA
06/2020 - 04/2017
2AntigensIBA
01/2020 - 05/2019
1Losartan (Cozaar)FDA LinkGeneric
10/2022
1PlasticsIBA
10/2022
1Ointments (Pastes)IBA
10/2022
1AngiotensinsIBA
10/2022
1SandIBA
05/2022
1Fluorouracil (Carac)FDA LinkGeneric
05/2022
1potassium hydroxideIBA
05/2022
1SolutionsIBA
05/2022
1Pharmaceutical PreparationsIBA
03/2022
1Naltrexone (ReVia)FDA LinkGeneric
03/2022
1Tuberculin (PPD)IBA
02/2022
1COVID-19 VaccinesIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
11/2021
1Ondansetron (Zofran)FDA LinkGeneric
05/2021
1N 30IBA
01/2021
1Long Noncoding RNAIBA
01/2021
1Histone Deacetylases (Histone Deacetylase)IBA
01/2021
1incobotulinumtoxinAFDA Link
12/2020
1Saline SolutionIBA
12/2020
1DesmogleinsIBA
10/2020
1Prostaglandins AIBA
10/2020
1Desmoglein 1IBA
10/2020
1Hematoxylin (Haematoxylon)IBA
04/2020
1MART-1 AntigenIBA
04/2020
1Eosine Yellowish-(YS) (Eosin)IBA
04/2020
1Interleukin-18 (Interleukin 18)IBA
02/2020
1Interleukin-10 (Interleukin 10)IBA
02/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2020
1Coloring Agents (Dyes)IBA
10/2019
1Formaldehyde (Formol)FDA Link
10/2019
1ParaffinIBA
10/2019
1FibrinIBA
07/2019
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2019
1AndrogensIBA
02/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2019
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2019
1CollagenIBA
01/2018

Therapy/Procedure

6Therapeutics
12/2021 - 09/2017
3Mammaplasty (Breast Reconstruction)
10/2022 - 12/2020
3Abdominoplasty
10/2022 - 12/2020
3Immunotherapy
01/2021 - 10/2019
2Lasers (Laser)
10/2022 - 02/2022
1Solid-State Lasers
10/2022
1Phototherapy (Light Therapy)
05/2022
1Hair Removal (Depilation)
02/2022
1Operative Surgical Procedures
12/2020
1Laser Therapy (Surgery, Laser)
11/2020
1Contraindications
01/2019
1Aftercare (After-Treatment)
01/2019
1Cupping Therapy
07/2018